Literature DB >> 66757

Some characteristics of Mozambican Shangaans with primary hepatocellular cancer.

M C Kew, R Marcus, E W Geddes.   

Abstract

Certain characteristics of 328 Mozambican male Shangaans with primary hepatocellular cancer (PHC) have been compared with those of 163 Shangaan men with hepatomegaly from causes other than PHC and with those of 122 Black Southern African men with the same tumour but who belonged to tribes other than the Shangaan. Shangaans with PHC were significantly younger than non-Shangaans with the tumour (mean age 33,4 cf. 40,0 years; Pless than 0,001). They also had a significantly higher positivity rate of alpha-fetoprotein by immunodiffusion (71,4%) than the non-Shangaans (16%), although in other respects the tumours appeared to be similar. Cirrhosis of the non-tumorous part of the liver was present at necropsy in 62% of the Shangaans and in 66% of the non-Shangaans. The hepatitis B (surface) antigen (HBsAg) was detected in the serum of 60% of the Shangaans with PHC compared with only 9% of the controls. The antigen was present in 53,4% of the non-Shangaans with PHC (the difference between this fifure and that in the Shangaans was not significant). HBsAg was detected in the serum of 64% of the Shangaans with PHC and cirrhosis, but also in 74% of those with the tumour without associated cirrhosis. The possible role of the hepatitis B verus in the aetiology of PHC is considered in the light both of these findings and of the possibility that the frequency with which the tumour is associated with cirrhosis may be decreasing in Shangaans. Some of the dietary habits of the Shangaans with PHC were compared with those of the controls. Virtually all the patients with PHC, but also almost all the controls, ate groundnuts in large quantities from an early age, as well as cashew nuts in smaller amounts. Cycad pips, mopani leaves and pods, mopani worms and locusts were not eaten by significantly more of the Shangaans with PHC than the controls. The limitations of this type of dietary analysis are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 66757

Source DB:  PubMed          Journal:  S Afr Med J


  11 in total

Review 1.  Geographic heterogeneity of hepatocellular carcinoma.

Authors:  K Okuda
Journal:  Gastroenterol Jpn       Date:  1990-12

2.  Hepatitis B and Hepatocellular Carcinoma Screening Practices in Chinese and African Immigrant-Rich Neighborhoods in New York City.

Authors:  S Fitzgerald; J Chao; Y Feferman; P Perumalswami; U Sarpel
Journal:  J Racial Ethn Health Disparities       Date:  2016-10-28

3.  Surveillance of hepatocellular carcinoma by medical imaging.

Authors:  Christoph F Dietrich; Andreas Teufel; Claude B Sirlin; Yi Dong
Journal:  Quant Imaging Med Surg       Date:  2019-11

4.  Hepatocellular carcinoma: Clinical-pathological features and HIV infection in Mozambican patients<sup/>.

Authors:  Lina Cunha; Carla Carrilho; Nilesh Bhatt; Michella Loforte; Cremildo Maueia; Fabíola Fernandes; Assucena Guisseve; Francisco Mbofana; Fatima Maibaze; Liana Mondlane; Muhammad Ismail; Luzmira Dimande; Sheila Machatine; Nuno Lunet; Yu-Tsueng Liu; Eduardo Samo Gudo; Pascal Pineau
Journal:  Cancer Treat Res Commun       Date:  2019-03-16

Review 5.  Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies.

Authors:  Cristina Della Corte; Alessio Aghemo; Massimo Colombo
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

Review 6.  Hepatitis B and C in African Americans: current status and continued challenges.

Authors:  Kimberly A Forde; Orapin Tanapanpanit; K Rajender Reddy
Journal:  Clin Gastroenterol Hepatol       Date:  2013-06-28       Impact factor: 11.382

Review 7.  Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit.

Authors:  Claus Niederau
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 8.  Epidemiology and Management of Hepatocellular Carcinoma.

Authors:  Laura Kulik; Hashem B El-Serag
Journal:  Gastroenterology       Date:  2018-10-24       Impact factor: 22.682

Review 9.  Surveillance for hepatocellular carcinoma in chronic liver disease: evidence and controversies.

Authors:  Suzanne van Meer; Robert A de Man; Peter D Siersema; Karel J van Erpecum
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

10.  Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Third Generation Nucleos(t)ides Analogs: Risk Factors and Performance of a Risk Score.

Authors:  Pedro Magalhães-Costa; Luís Lebre; Paula Peixe; Sofia Santos; Cristina Chagas
Journal:  GE Port J Gastroenterol       Date:  2016-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.